ARTICLE | Clinical News
Reolysin: Completed Phase I enrollment
August 20, 2012 7:00 AM UTC
Oncolytics completed enrollment of 21 patients in the single-arm, dose-escalation U.S. Phase I REO 022 trial evaluating Reolysin in combination with FOLFIRI chemotherapy in patients with oxaliplatin-r...